{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:08Z","timestamp":1785545048658,"version":"3.56.0"},"reference-count":28,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Clinical outcomes for patients with cystic fibrosis have improved over the last decades, with a focus on enhancing the quality of life for children and their families. These improvements are expected to reduce the need for in-hospital visits, allowing for alternative care provisions that further enhance their quality of life. Telehealth can decrease the number of in-hospital visits and disruptions to everyday life.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to assess the feasibility of home monitoring with subsequent video consultations and to explore the experiences of families and health care professionals.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We recruited 12 children with cystic fibrosis (>6 y) and their parents from the Cystic Fibrosis-Center Copenhagen. The 5-month intervention consisted of alternately standard care visits and telehealth care visits. Telehealth care visits consisted of home monitoring, with automatically transmitted data to the hospital-based electronic health record. Home monitoring included spirometry, weight, and oxygen saturation, conducted with parental support, along with a video consultation. To monitor lung infections during telehealth care visits, all participants were encouraged to send in a sputum sample beforehand. Families completed preintervention and postintervention questionnaires about time spent, sense of security, and usability of home monitoring devices. We also collected data on families\u2019 and health care professionals\u2019 experiences with telehealth care visits through semistructured interviews after the intervention.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n All 12 (100%) approached children and their parents accepted to participate. Standard care visits caused full-day absences for 8 (73%) children and 10 (91%) parents, compared to only 1 (8%) child and their parents during telehealth visits. More than 70% of children and their parents rated the oxygen saturation device (n=9, 75%) and weighing scale (n=11, 92%) as \u201cvery easy\u201d to use after the intervention. However, 50% (n=6) found the home spirometry device \u201cdifficult\u201d or \u201cacceptable\u201d to use, possibly due to device errors. We identified 4 main themes in the interviews: benefits of telehealth, disadvantages of telehealth, prerequisites for telehealth to be successful, and next steps toward telehealth.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Home monitoring with automatically transmitted data to the hospital-based electronic health record and video consultations was feasible despite identified concerns regarding technical issues with home spirometry devices.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/80722","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:10:08Z","timestamp":1768576208000},"page":"e80722-e80722","source":"Crossref","is-referenced-by-count":0,"title":["Telehealth by Home Monitoring and Video Consultation for Children With Cystic Fibrosis: Qualitative and Quantitative Study"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9362-3510","authenticated-orcid":false,"given":"Maria N\u00f8reg\u00e5rd","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5906-9449","authenticated-orcid":false,"given":"Kim Gjerum","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0790-5368","authenticated-orcid":false,"given":"Mathias","family":"Aalling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-0248","authenticated-orcid":false,"given":"Ragnheidur","family":"Traustadottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6911-3121","authenticated-orcid":false,"given":"Helena","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00018-016-2393-9","article-title":"Cystic fibrosis: a clinical view","volume":"74","author":"Castellani","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"R2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","journal-title":"J Cyst Fibros"},{"issue":"21","key":"R3","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","journal-title":"JAMA"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5603\/PiAP.2014.0003","article-title":"Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire","volume":"82","author":"Uchmanowicz","journal-title":"Pneumonol Alergol Pol"},{"issue":"3","key":"R5","doi-asserted-by":"publisher","DOI":"10.3390\/children10030554","article-title":"Efficacy and safety of elexacaftor-tezacaftor-ivacaftor in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Kapouni","journal-title":"Children (Basel)"},{"issue":"11","key":"R6","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1164\/rccm.202202-0392OC","article-title":"Efficacy and safety of elexacaftor\/tezacaftor\/ivacaftor in children 6 through 11 years of age with cystic fibrosis heterozygous for and a minimal function mutation: a phase 3b, randomized, placebo-controlled study","volume":"206","author":"Mall","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","journal-title":"J Cyst Fibros"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","journal-title":"J Cyst Fibros"},{"issue":"6","key":"R9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jcf.2024.08.007","article-title":"Cystic fibrosis foundation position paper: redefining the CF care model","volume":"23","author":"Goetz","journal-title":"J Cyst Fibros"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.09.005","article-title":"Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic","volume":"20 Suppl 3","author":"Solomon","journal-title":"J Cyst Fibros"},{"issue":"8","key":"R11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1089\/tmj.2020.0091","article-title":"A feasibility study of urgent implementation of cystic fibrosis multidisciplinary telemedicine clinic in the face of COVID-19 pandemic: single-center experience","volume":"26","author":"Compton","journal-title":"Telemed J E Health"},{"issue":"2","key":"R12","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.jcf.2021.10.010","article-title":"Management of cystic fibrosis during COVID-19: patient reported outcomes based remote follow-up among CF patients in Denmark\u2014a feasibility study","volume":"21","author":"Rodkj\u00e6r","journal-title":"J Cyst Fibros"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.08.034","article-title":"Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs","volume":"20 Suppl 3","author":"Gifford","journal-title":"J Cyst Fibros"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jcf.2021.09.018","article-title":"The feasibility of home monitoring of young people with cystic fibrosis: results from CLIMB-CF","volume":"21","author":"Edmondson","journal-title":"J Cyst Fibros"},{"issue":"4","key":"R15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ppul.23950","article-title":"Impact of home spirometry on medication adherence among adolescents with cystic fibrosis","volume":"53","author":"Shakkottai","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.chest.2021.11.035","article-title":"Real-world outcomes in cystic fibrosis telemedicine clinical care in a time of a global pandemic","volume":"161","author":"Somerville","journal-title":"Chest"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.healun.2023.01.010","article-title":"Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function","volume":"42","author":"Odisho","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"R18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/hex.13092","article-title":"The challenges of caring for children who require complex medical care at home: \u201cThe go between for everyone is the parent and as the parent that\u2019s an awful lot of responsibility\u201d","volume":"23","author":"Page","journal-title":"Health Expect"},{"issue":"2","key":"R19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/27527530221140065","article-title":"Ambiguous expectations of parent caregiving for the child and adolescent with cancer at the hospital and at home-an ethnographic study","volume":"40","author":"Roug","journal-title":"J Pediatr Hematol Oncol Nurs"},{"key":"R20","unstructured":"Patton MQ . Qualitative Evaluation and Research Methods. 2nd ed. SAGE Publications; 1990. ISBN: 9780803937796"},{"issue":"2","key":"R21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","journal-title":"Qual Res Psychol"},{"issue":"4","key":"R22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1177\/1357633X16649532","article-title":"The use of telehealth (text messaging and video communications) in patients with cystic fibrosis: a pilot study","volume":"23","author":"Gur","journal-title":"J Telemed Telecare"},{"issue":"11","key":"R23","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/apa.13996","article-title":"Telephone monitoring and home visits significantly improved the quality of life, treatment adherence and lung function in children with cystic fibrosis","volume":"106","author":"Chrysochoou","journal-title":"Acta Paediatr"},{"issue":"3","key":"R24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/JCM.02214-15","article-title":"Detection of airway colonization by aspergillus fumigatus by use of electronic nose technology in patients with cystic fibrosis","volume":"54","author":"de Heer","journal-title":"J Clin Microbiol"},{"issue":"3","key":"R25","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.jcf.2021.03.009","article-title":"Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19","volume":"20","author":"Jaclyn","journal-title":"J Cyst Fibros"},{"issue":"2","key":"R26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jcf.2025.02.011","article-title":"AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations","volume":"24","author":"Mazurek","journal-title":"J Cyst Fibros"},{"issue":"8","key":"R27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-051844","article-title":"Factors influencing the effectiveness of remote patient monitoring interventions: a realist review","volume":"11","author":"Thomas","journal-title":"BMJ Open"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2021.100270","article-title":"Telemedicine in cystic fibrosis","volume":"26","author":"Desimone","journal-title":"J Clin Transl Endocrinol"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e80722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:26:38Z","timestamp":1785536798000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e80722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2196\/80722","relation":{},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"v10i1e80722"}}